Stock Market News 8 October 2025

AMD’s AI Mega-Deal Sparks Stock Surge – Inside the OpenAI Partnership, New Chips & Showdown with Rivals

AMD Stock Skyrockets on AI Mega-Deal: Inside the 2025 Rally, Financials & Rivalry

AMD’s headquarters sign in Silicon Valley. The company’s stock has surged amid blockbuster AI deals and strong chip demand in 2025. Stock Performance & Recent Rally Advanced Micro Devices (AMD) has been one of 2025’s top semiconductor stocks, staging a dramatic

8 October 2025

Duolingo Stock Surges on AI Buzz – Latest Price, Bold Forecasts & Big Risks in 2025

Stock Price & Recent Performance Duolingo’s stock has experienced whiplash in 2025. After a strong first half, DUOL tumbled nearly 50% from summer highs, erasing most of its prior 12-month gains marketbeat.com. Over the past three months the stock slid 35%, dramatically

8 October 2025

Artificial Intelligence · Duolingo · Investment Risks · Market Forecasts · NASDAQ:DUOL · Stock Market

Amazon’s Finance Teams Unleash AI for Complex Tasks – Transforming Corporate Finance

Amazon Stock Surges on New AI Push – Latest Price, Key News & 2025 Outlook

Stock Price & Recent Performance (October 2025) As of October 8, 2025, Amazon’s stock trades around $225 per share stockanalysis.com. It has risen modestly in early October, bouncing from about $219 at the start of the month to the mid-$220s range stockanalysis.com.

8 October 2025

Amazon · Artificial Intelligence · Financial News · Investment Trends · NASDAQ:AMZN · Stock Market

Tempus AI (TEM) Stock Skyrockets on AI Healthcare Breakthroughs – What Investors Need to Know

Company Overview and Mission Tempus AI, Inc. is an American health technology company founded in 2015 by entrepreneur Eric Lefkofsky (best known as co-founder of Groupon). Headquartered in Chicago, Tempus was born from Lefkofsky’s personal mission to improve cancer care after his wife’s battle

8 October 2025

Artificial Intelligence · Healthcare Innovation · Investing Tips · NASDAQ:TEM · Stock Market · Technology News

Xenetic Biosciences (XBIO) Stock Skyrockets – Is the Biotech’s 2025 Rally for Real?

Stock Performance: The 2025 Rollercoaster Ride Xenetic’s stock was relatively quiet for most of 2025 until early October, when it suddenly erupted. By Oct 8, 2025, XBIO had skyrocketed to levels not seen in years. On that day alone, the stock soared

8 October 2025

2025 Outlook · Biotechnology · Financial News · NASDAQ:XBIO · Pharma Investing · Stock Market

Plant-Based Food Stock Goes Crypto: Above Food (ABVE) Skyrockets in 2025

Above Food Ingredients Inc. is a Canadian plant-based food tech company that went public via SPAC merger in 2024 stocktwits.com. In 2025, its stock ABVE has been on a wild ride – climbing from penny-stock levels to over $4, an almost 8-fold increase in under a year

8 October 2025

Cryptocurrency · Financial News · Investment Trends · NASDAQ:ABVE · Plant-Based Foods · Stock Market

Cipher Mining (CIFR) Stock Skyrockets on AI Pivot & Bitcoin Boom – Next Crypto Powerhouse?

Company Overview: Operations & Business Model Cipher Mining Inc. is a pure-play Bitcoin miner operating industrial-scale data centers with a focus on ultra-low-cost power ts2.tech. The company strategically locates its facilities in regions with cheap, renewable-rich electricity (e.g. West Texas), often building behind-the-meter or

8 October 2025

Artificial Intelligence · Cryptocurrency · Financial News · Investment Strategies · NASDAQ:CIFR · Stock Market

Adaptimmune Therapeutics (ADAP) Stock Skyrockets 42% – Is This Biotech Turnaround for Real?

Therapy (Target) Indication Status (2025) Current Ownership TECELRA(afamitresgene, targets MAGE-A4) Synovial sarcoma (unresectable/metastatic) FDA approved Aug 2024 biospace.com; ~16 patients treated in launch year nasdaq.com. Sold to US WorldMeds (2025) adaptimmune.com Letetresgene (lete-cel, NY-ESO-1) MRCLS and synovial sarcoma (advanced solid tumors) Phase

8 October 2025

Biotech · Company Analysis · Financial News · Investing · NASDAQ:ADAP · Stock Market

Snowflake Stock Soars on AI Boom – Inside SNOW’s 2025 Rally and What’s Next

Below, we dive deeper into each of these areas – from Snowflake’s business model and financials to the latest news, analyst insights, competitive dynamics, and what to expect going forward. Company Overview and Business Model Snowflake Inc. is a cloud data

8 October 2025

Artificial Intelligence · Financial Analysis · Investing · NYSE:SNOW · Stock Market · Technology

CrowdStrike Stock Skyrockets Amid Cybersecurity Boom – Is the Rally Justified? (2025 Update)

Sources: Official company reports and press releases; Yahoo Finance and Zacks Investment Research; Reuters and CNBC interviews; TS2 Tech stock analysis and cybersecurity news ts2.tech nasdaq.com markets.financialcontent.com marketbeat.com ts2.tech siliconangle.com ts2.tech. These provide the latest financial data, expert commentary, and industry context

8 October 2025

Cybersecurity · Financial News · Investment Analysis · NASDAQ:CRWD · Stock Market · Technology Trends

Moderna, Inc. (MRNA) Stock Update – Oct 8 2025: Will the mRNA Trailblazer Bounce Back or Sink Further?

Detailed Report 1. Stock Performance and Valuation Moderna’s stock was a market darling during the pandemic but has suffered a long decline. On Oct 7 2025 (the last trading day before the U.S. Columbus Day holiday), the stock closed at $27.34, down

8 October 2025

Biotechnology · Company News · Financial Analysis · Investing · NASDAQ:BNTX · NASDAQ:MRNA · NYSE:MRK · Stock Market

Intellia Therapeutics (NTLA) Soars on CRISPR Breakthroughs – Latest Updates & Stock Outlook

Intellia at a Glance: CRISPR Trailblazer in 2025 Intellia Therapeutics, Inc. (NASDAQ: NTLA) is a clinical-stage biotechnology company at the forefront of CRISPRgene editing medicines. Headquartered in Cambridge, MA, Intellia was one of the first companies to harness CRISPR-Cas9 technology to

8 October 2025

Biotechnology · Gene Editing · Investment Analysis · NASDAQ:NTLA · Pharmaceutical News · Stock Market